Predire Paris Skin Shield Protector Mineral Defense Cream
Generic Name: predire paris skin shield protector mineral defense cream
Brand Names:
Predire Paris Skin Shield Protector Mineral Defense Cream
Purpose Sunscreen
Overview
Purpose Sunscreen
Uses
Uses Helps prevent sunburn If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Dosage
Directions Apply liberally 15 minutes before sun exposure. Reapply every two hours. Water- resistant up to 40 minutes.
Side Effects
When using this product When using this product, keep out of eyes. Rinse with water to remove. Stop use Stop use and ask a doctor if rash occurs.
Warnings
Warnings For external use only. Do not use Do not use on damaged or broken skin.
Storage
Other information Store at room temperature
Frequently Asked Questions
What is Predire Paris Skin Shield Protector Mineral Defense Cream used for?▼
Uses Helps prevent sunburn If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
What are the side effects of Predire Paris Skin Shield Protector Mineral Defense Cream?▼
When using this product When using this product, keep out of eyes. Rinse with water to remove. Stop use Stop use and ask a doctor if rash occurs.
What are the important warnings for Predire Paris Skin Shield Protector Mineral Defense Cream?▼
Warnings For external use only. Do not use Do not use on damaged or broken skin.
Related Medications
Nemolizumab-ilto
nemolizumab-ilto
Interleukin-31 Receptor alpha Antagonist [EPC]
11 DESCRIPTION Nemolizumab-ilto, an interleukin-31 receptor alpha (IL-31RA) antagonist, is a humanized monoclonal modified immunoglobulin G (IgG) antibody with a molecular weight of approximately 144 kDa. Nemolizumab-ilto is produced by recombinant DNA technology in Chinese Hamster Ovary cells. NEMLUVIO (nemolizumab-ilto) for injection is a sterile, preservative-free, white lyophilized powder in a dualchamber, single-dose, prefilled pen for subcutaneous use.
Quinapril And Hydrochlorothiazide 20/25
quinapril and hydrochlorothiazide 20/25
Thiazide Diuretic [EPC]
DESCRIPTION Quinapril and hydrochlorothiazide tablets, USP are fixed-combination tablet that combines an angiotensin-converting enzyme (ACE) inhibitor, quinapril hydrochloride, and a thiazide diuretic, hydrochlorothiazide. Quinapril hydrochloride, USP is chemically described as [3S-[2[R*(R*)], 3R*]]-2-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, monohydrochloride. Its empirical formula is C 25 H 30 N 2 O 5 .
Pembrolizumab
pembrolizumab
Programmed Death Receptor-1 Blocking Antibody [EPC]
11 DESCRIPTION Pembrolizumab is a programmed death receptor-1 (PD 1)-blocking antibody. Pembrolizumab is a humanized monoclonal IgG4 kappa antibody with an approximate molecular weight of 149 kDa. Pembrolizumab is produced in recombinant Chinese hamster ovary (CHO) cells. KEYTRUDA (pembrolizumab) injection is a sterile, preservative-free, clear to slightly opalescent, colorless to slightly yellow solution for intravenous use. Each vial contains 100 mg of pembrolizumab in 4 mL of solution.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.